Advancing excellence in laboratory medicine for better healthcare worldwide

About us (C-EBLM)

Terms of reference

The aims and objectives of the Committee on Evidence-based Laboratory Medicine are to:

1.       Promote the understanding and the methodology of EBLM by educating laboratory professionals about

  • how to find the evidence
  • how to appraise the evidence
  • how to act on evidence

2.       Support rational laboratory use by implementation of results from EBLM into daily practice. This can be achieved by methodological  research, international surveys and by educating laboratory professionals in the following topics:

  • How to perform primary diagnostic studies
  • How to carry out systematic reviews in laboratory medicine
  • How to make evidence-based guideline recommendations in laboratory medicine
  • How to implement evidence-based diagnostic guidelines in clinical practice

3.       Promote the international dissemination of and collaboration in EBLM

Committee membership

Terms of members are indicated in the C-EBLM page of the IFCC website


Members are indicated in the C-EBLM page of the IFCC website


  • Wytze P Oosterhuis, Department of Clinical Chemistry, St. Elisabeth Hospital, Hilvarenbeekseweg 60, Tilburg, 5022 GC, The Netherlands: (former member of IFCC EMD EPO WG; former member of C-EBLM)
  • Sverre Sandberg, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen N-5021, Norway: (former chair of IFCC's TF on Global Campaign on diabetes mellitus; former chairman of C-EBLM)

List of Corresponding Members, nominated by National Societies

NameFull Member Society
A. Fares TaieConfederacion Unificada Bioquimica de la Republica Argentina (CUBRA)
D. RogicCroatian Society for Medical Biochemistry (HDMB)
R. LangeGerman Society of Clinical Chemistry and Laboratory Medicine
V. TakhurAssociation of Clinical Biochemists of India (ACBI)
Y. DicksteinIsrael Society for Clinical Laboratory Science
P. PezzatiItalian Society of Clinical Chemistry and Clinical Molecular Biology (SIBioC)
M. MurakamiJapan Society of Clinical Chemistry (JSCC)
V. BanysLithuanian Society of Laboratory Medicine
H. IsahAssociation of Clinical Chemists Nigeria (ACCN)
H.K.AyeshaPakistan Society of Chemical Patholosgists
G.J. SousaPortugese Society of Clinical Chemistry (SPQC)
N. Majkic SinghSociety of Medical Biochemists of Serbia (SMBS)
J. VavrikSlovak Society of Clinical Biochemistry (SSKB)
X. FilellaSociedad Española de Medicina de Laboratorio (SEQCML)
C. QueijoAssociation Bioquimica Uruguaya (ABU)
S. KahnAmerican Association for Clinical Chemistry (AACC)
S. DemirTurkish Biochemical Society (TBS)
R.Vinod MahatoNepalese Association for Clinical Chemistry (NAAC)

List of Corresponding Members, nominated by Corporate Members

R. SchneiderAbbott Laboratories
R. ThomaePHC Europe B.V.
K. OlsonSiemens Healthcare Diagnostics

How to become a member or corresponding member of the committee?

The organisational framework of IFCC Divisions and Committees can be viewed in the IFCC handbook.

To become a member or corresponding member of the committee, candidates should submit a formal application with a brief plan (max. 250 words) of their contribution to the aims and objectives of the C-EBLM. A short CV (max. 1 page), underlining the qualifications and prior experience or publications in evidence-based (laboratory) medicine, should also be attached. Members and corresponding members should be officially recommended by their National Society and a formal letter of support should accompany the application. Applications will be reviewed and officially endorsed by the Executive Committee of the Education and Management Division (EC-EMD) of IFCC, and the EMD and/or C-EBLM chair will officially inform successful candidates.

Applications, including:

  • the application form
  • a letter of support signed by the president of the candidate's national society, and
  • curriculum vitae of the candidate

should be addressed to the chairperson of the committee

Members should have prior knowledge and experience in EBM or EBLM. Members are expected to participate actively in the activities of the Committee. Membership involves approximately 2-3 days commitment per month. Failure to contribute significantly may result in the loss of membership.

Corresponding members: The committee is open to corresponding membership from member organisations of IFCC. One corresponding member should represent the IFCC member state in the committee. Applications are welcome from countries which are not yet represented in the committee (see membership area). Corresponding members should be interested in evidence based medicine. Prior experience in evidence-based methodology is an advantage. Candidates should be active in EBLM or related fields in their own countries. Corresponding members are expected to form a link and a communication channel between the C-EBLM and the relevant national professional organisation(s).

Corresponding membership involves approximately one day commitment per month.

Consultants are either former members of C-EBLM or external experts who support the activities of the committee and advise on specific matters, at the request of the chairperson of the committee.


Website developed by Insoft